Headquartered in Singapore, Growth & Emerging Markets (GEM) Business Unit has a presence in 35 countries across five diverse geographic Areas: Asia Pacific (excluding Japan), China, Latin America, Middle East & Africa, and Russia-CIS.
We are committed to bringing to patients our trusted and proven medicines, as well as launching an innovative pipeline of potentially life-saving medicines in the therapy areas of GI, Oncology, and CVM.
Encompassing approximately 80% of the world’s population, the Growth & Emerging Markets Region is characterized by a broad range of patient needs, country-specific challenges and rapidly rising demands for healthcare services and medicines.
Takeda has received external recognition in many countries across the Region from several global, third-party organizations in the sphere of HR. These awards are a testament to our committment to enable our people to develop and progress their careers.
Current award-winners include our operations in: Argentina, Australia, Brazil, China, Colombia, Ecuador, Hong Kong, Malaysia, Mexico, Peru, Philippines, Russia, Singapore, South Africa, South Korea, Taiwan, Thailand, Turkey, Ukraine, Venezuela.
21 Biopolis Road, Singapore, 138567
+65 6808 9400
+65 6822 0228